White Pine Capital LLC grew its position in The Joint Corp. (NASDAQ:JYNT) by 44.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,500 shares of the company’s stock after acquiring an additional 17,000 shares during the period. White Pine Capital LLC owned 0.42% of The Joint Corp. worth $211,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Boston Partners raised its stake in shares of The Joint Corp. by 13.1% in the second quarter. Boston Partners now owns 150,900 shares of the company’s stock valued at $573,000 after acquiring an additional 17,500 shares during the last quarter. Russell Investments Group Ltd. raised its stake in shares of The Joint Corp. by 24.9% in the second quarter. Russell Investments Group Ltd. now owns 87,900 shares of the company’s stock valued at $334,000 after acquiring an additional 17,500 shares during the last quarter. Finally, Sanders Morris Harris LLC raised its stake in shares of The Joint Corp. by 0.5% in the second quarter. Sanders Morris Harris LLC now owns 2,619,807 shares of the company’s stock valued at $9,955,000 after acquiring an additional 12,000 shares during the last quarter. Institutional investors own 47.03% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/09/12/the-joint-corp-jynt-shares-bought-by-white-pine-capital-llc.html.

In related news, Director James H. Amos, Jr. acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 30th. The stock was acquired at an average price of $3.85 per share, with a total value of $38,500.00. Following the purchase, the director now directly owns 57,295 shares in the company, valued at $220,585.75. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO John P. Meloun acquired 6,850 shares of the company’s stock in a transaction that occurred on Tuesday, June 27th. The stock was bought at an average cost of $3.69 per share, with a total value of $25,276.50. The disclosure for this purchase can be found here. In the last three months, insiders purchased 20,670 shares of company stock valued at $78,140. 6.10% of the stock is owned by insiders.

The Joint Corp. (JYNT) opened at 4.94 on Tuesday. The company has a 50-day moving average of $3.98 and a 200 day moving average of $3.90. The company’s market cap is $65.10 million. The Joint Corp. has a 52-week low of $1.96 and a 52-week high of $5.07.

The Joint Corp. (NASDAQ:JYNT) last issued its quarterly earnings data on Thursday, August 10th. The company reported ($0.08) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. The business had revenue of $6.02 million during the quarter, compared to the consensus estimate of $5.76 million. The Joint Corp. had a negative net margin of 48.08% and a negative return on equity of 103.25%. Equities research analysts predict that The Joint Corp. will post ($0.33) EPS for the current year.

JYNT has been the subject of a number of research analyst reports. Maxim Group reiterated a “buy” rating and issued a $7.00 target price on shares of The Joint Corp. in a research note on Friday, August 11th. Roth Capital initiated coverage on shares of The Joint Corp. in a research report on Thursday, July 27th. They issued a “buy” rating and a $5.70 price objective for the company. Zacks Investment Research cut shares of The Joint Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, May 17th. Craig Hallum initiated coverage on shares of The Joint Corp. in a research report on Wednesday, June 14th. They issued a “buy” rating and a $5.75 price objective for the company. Finally, ValuEngine upgraded shares of The Joint Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, June 6th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $5.61.

The Joint Corp. Profile

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Institutional Ownership by Quarter for The Joint Corp. (NASDAQ:JYNT)

Receive News & Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related companies with MarketBeat.com's FREE daily email newsletter.